Qian D, Hu Q, Liu L N, Tan Q Q, Bai J
Chongqing Bai Ji Eye Clinic, Chongqing 400042, China.
Zhonghua Yan Ke Za Zhi. 2024 Aug 11;60(8):680-688. doi: 10.3760/cma.j.cn112142-20240311-00106.
To evaluate the efficacy of optimized monovision correction using small incision lenticule extraction (SMILE) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) in myopic patients with presbyopia and to assess the corneal epithelial remodeling following these procedures. A prospective study was conducted. Thirty-two patients (64 eyes) with myopia and presbyopia who underwent surgical correction at Chongqing Bai Ji Eye Clinic from August 2021 to April 2023 were continuously included. There were 9 males and 23 females, with an average age of (44.25±2.96) years. The dominant eyes (32 eyes) underwent SMILE, while the non-dominant eyes (32 eyes) underwent FS-LASIK with mild myopia and partial negative spherical aberration induction. Data on visual acuity and refraction were collected preoperatively and at 1 week, 1 month, 3 months, and 6 months postoperatively. Total ocular aberrations were measured using the iProfiler Plus, and the corneal epithelial thickness in different regions was assessed using anterior segment optical coherence tomography. Safety and efficacy indices were calculated based on visual acuity, the defocus and contrast sensitivity were measured using the Binoptometer 4P binocular vision tester, and a patient satisfaction survey was performed. At 1 week postoperatively, the uncorrected distance visual acuity (UDVA) of dominant eyes significantly improved compared to preoperative values. At 3 months postoperatively, the uncorrected near visual acuity (UNVA) of non-dominant eyes showed significant improvement (0.05), 96.9% (31 eyes) of the dominant eyes achieved UDVA of 1.0 or better, and 93.8% (30 eyes) of the non-dominant eyes achieved UNVA of 0.8 or better. The safety index for distance vision was 1.15±0.09, and the efficacy index was 1.15±0.11. At 1 week, 1 month, 3 months, and 6 months postoperatively, the proportion of dominant eyes with a spherical equivalent (SE) deviation within ±0.50 D of the target was 90.6% (29 eyes), 90.6% (29 eyes), 93.8% (30 eyes), and 96.2% (31 eyes), respectively; for non-dominant eyes, the corresponding proportions were 81.3% (26 eyes), 87.5% (28 eyes), 93.8% (30 eyes), and 96.2% (31 eyes). The postoperative spherical aberration was (0.11±0.03) μm for dominant eyes and (-0.01±0.04) μm for non-dominant eyes, showing a statistically significant difference (0.05). At 1 week and 1 month postoperatively, the central corneal epithelial thickness of non-dominant eyes was significantly higher than that of dominant eyes [(71.34±21.69) μm . (51.97±6.33) μm at 1 week, and (61.34±15.85) μm (52.72±6.32) μm at 1 month; 0.05]. Patient satisfaction was high, with 96.9% (31 patients) rating their satisfaction as "satisfactory" or higher. The combined use of SMILE and FS-LASIK for optimized monovision correction in myopic patients with presbyopia is both safe and effective, achieving high postoperative satisfaction. The SMILE procedure reduces the extent of corneal epithelial remodeling compared to FS-LASIK.
评估采用小切口飞秒透镜切除术(SMILE)和飞秒激光原位角膜磨镶术(FS-LASIK)进行优化单眼视力矫正对近视合并老花眼患者的疗效,并评估这些手术后的角膜上皮重塑情况。进行了一项前瞻性研究。连续纳入2021年8月至2023年4月在重庆佰视佳眼科诊所接受手术矫正的32例近视合并老花眼患者(64只眼)。其中男性9例,女性23例,平均年龄(44.25±2.96)岁。优势眼(32只眼)接受SMILE手术,非优势眼(32只眼)接受FS-LASIK手术并诱导轻度近视和部分负球差。术前及术后1周、1个月、3个月和6个月收集视力和验光数据。使用iProfiler Plus测量全眼像差,使用眼前节光学相干断层扫描评估不同区域的角膜上皮厚度。根据视力计算安全性和有效性指标,使用Binoptometer 4P双眼视觉测试仪测量散焦和对比敏感度,并进行患者满意度调查。术后1周,优势眼的未矫正远视力(UDVA)较术前显著提高。术后3个月,非优势眼的未矫正近视力(UNVA)显著改善(P<0.05),96.9%(31只眼)的优势眼达到UDVA为1.0或更好,93.8%(30只眼)的非优势眼达到UNVA为0.8或更好。远视力的安全指数为1.15±0.09,有效性指数为1.15±0.11。术后1周、1个月、3个月和6个月,优势眼等效球镜度(SE)偏差在目标值±0.50 D以内的比例分别为90.6%(29只眼)、90.6%(29只眼)、93.